PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 30, 20260 citationsOpen Access

Development and analytical qualification of a cell-based potency assay for mRNA COVID-19 vaccines

View Full Paper
IAIngrid AraujoASAndrea SilvaJSJane Silva

Key Points

  • To develop and analytically qualify a cell-based potency assay for mRNA COVID-19 vaccines.
  • Developed a cell-based potency assay.
  • Analyzed vaccine efficacy through immunobiological parameters.
  • Results indicate effective measurement of vaccine potency.
  • Assay shows reliable and reproducible outcomes in testing.

Abstract

Os autores externos submeteram sua publicação para apresentação de trabalho no evento 'International Symposium on Immunobiologicals', que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Araujo et al. (2026) studied this question.

synapsesocial.com/papers/6a1a7dc00307b78509430c6chttps://doi.org/10.35259/isi.2026_76357
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ensuring mRNA vaccine identity: qualification of an RT-qPCR assay for COVID-19 vaccine verification2026
  2. 2Analytical technology transfer for mRNA vaccine quality control2026
  3. 3Method qualification for the assessment of mRNA vaccine encapsulation efficiency2026
  4. 4Implementation of documents and workflow for internal technology transfer of analytical methods at LATIM in development of an mRNA COVID-19 vaccine2026
  5. 5Analysis of aggregates in naked mRNA and mRNA extracted from lipid nanoparticles in a mRNA vaccine against COVID-192026